Michael Burry Says Palantir Valuation Sparks Debate
Palantir sits around $130 as Michael Burry’s $46 valuation challenge re-emerges, forcing a sharper look at growth, ma...
Understand the key signals that trigger rebalancing in retirement portfolios to act promptly and protect objectives.
13,016 articlesPalantir sits around $130 as Michael Burry’s $46 valuation challenge re-emerges, forcing a sharper look at growth, ma...
With spring housing activity picking up, brokers argue that broad listing exposure through MLS remains essential for ...
Csenge Advisory Group boosted its stake in the First Trust LMBS ETF during Q4, signaling confidence in short-duration...
Dell Technologies posted a billion-dollar quarter, driven by AI server orders that surged in Q4 and propelled a raise...
A potential U.S. strike on Iran could squeeze global oil supplies and push prices higher, forcing households and inve...
As March arrives, the quantum computing space presents both risk and opportunity. This guide highlights two sturdy pi...
Peabody Energy stock 120% gains grab headlines, but what do they mean for real-world portfolios? This guide breaks do...
Qualcomm nudges the industry toward 6G with a bold roadmap. Investors are weighing the potential for faster networks ...
A fresh $3.4 million investment in Northeast Bank by PMC FIG Opportunities highlights growing interest in regional le...
SoFi stock fell last month, sparking questions about the growth story and valuation. This article breaks down the fac...
U.S. labor data at month-end point to a cooling but stable job market, with initial claims around the low 200,000s an...
Regencell Bioscience sits in the high-risk, high-reward world of early-stage biotech. Before you consider investing, ...